查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003130

5G賦能醫療設備市場：2026-2032年全球市場預測（依產品類型、連接方式、網路架構、組件、應用和最終用戶分類）

5G-enabled Medical Devices Market by Product Type, Connectivity Type, Network Architecture, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，5G醫療設備市場價值將達到 12.2 億美元，到 2026 年將成長到 15.1 億美元，到 2032 年將達到 53.8 億美元，複合年成長率為 23.62%。

主要市場統計數據
基準年 2025 12.2億美元
預計年份：2026年 15.1億美元
預測年份 2032 53.8億美元
複合年成長率 (%) 23.62%

這是一本權威的入門指南，概述了第五代通訊技術如何重新定義整個醫療保健生態系統中的臨床設備和交付模式。

第五代無線通訊技術的引入正在改變醫療設備在臨床和非臨床環境中的設計、交付和管理方式。本報告探討了確定性連接、超低延遲和高設備密度如何催生新型診斷、監測和治療設備，同時也對網路安全、法規遵循和臨床檢驗檢驗了新的要求。從醫療設備製造商到醫療系統營運商和網路供應商，相關人員面臨著一個快速發展的技術和商業性環境，在這個環境中，互通性、資料完整性和病患安全是創新與監管的交匯點。

簡要分析加速臨床級連接技術普及和提高其標準的關鍵技術、監管和營運變革。

近年來，一系列變革加速了互聯醫療設備的普及應用，並重塑了臨床工作流程。首先，邊緣運算和分散式分析技術的成熟降低了資料擷取與臨床操作之間的門檻，從而在關鍵應用場景中實現了即時決策支援。同時，私有網路和混合網路的日益普及建構了可控的互聯環境，能夠有效管理延遲、吞吐量和安全參數，滿足臨床層級要求。

對 2025 年美國關稅措施對供應鏈策略、採購趨勢和醫療設備部署計畫的影響進行現實評估。

美國2025年實施的關稅政策對依賴全球零件採購的醫療設備製造商的供應鏈、籌資策略和產品成本結構產生了一系列累積影響。依賴海外製造的無線設備、半導體模組或專用感測器的製造商正面臨不斷上漲的到貨成本和更長的前置作業時間，迫使他們重新評估採購管道和庫存管理優先順序。這些壓力正推動供應商多元化、增加關鍵零件的國內採購以及建立策略夥伴關係關係，以減輕未來政策變化的影響。

全面而全面的細分分析，展示了產品類型、應用、最終用戶、連接方式、架構和組件如何影響策略和設計。

細分分析揭示了不同設備類型、應用領域、最終用戶、連接方式、網路架構和組件堆疊的部署模式和產品設計優先級差異。在產品類型細分中，診斷設備包括影像設備、臨床實驗室設備和照護現場診斷設備。影像設備進一步細分為CT掃描儀、MRI掃描儀和超音波診斷設備，而臨床實驗室設備則分為血液分析儀和尿液檢查。這些高頻寬、高精度設備優先考慮吞吐量、確定性連接和安全的資料管道。監測設備包括心電圖（ECG）監測、血糖監測、呼吸監測和生命徵象監測。心電圖監測分為家庭使用和醫院使用，血糖監測分為連續測量和間歇測量，呼吸監測涵蓋睡眠呼吸中止症候群和肺功能測試，生命徵象監測涵蓋血壓、心率和體溫。低功耗、遙測連續性和強大的邊緣分析能力是這些監測領域的優先考慮因素。治療設備包括輸液幫浦、胰島素幫浦、神經刺激設備和呼吸治療設備。輸液幫浦分為胰島素輸注幫浦和鎮痛輸注幫浦；胰島素幫浦分為貼片式和管式；神經刺激設備分為深部腦部刺激器和脊髓刺激設備；呼吸治療設備分為持續性正壓呼吸器（CPAP）機和人工呼吸器。治療設備領域對連接可靠性、故障安全運作以及設備間的嚴格互通性提出了極高的要求。

戰略區域概覽，描述了美洲、歐洲、中東和非洲以及亞太地區等各個區域如何展現其獨特的採用促進因素和部署重點。

區域趨勢對5G醫療設備的技術採納曲線、監管重點和商業性夥伴關係產生了顯著影響。在美洲，學術醫療中心私人網路的試點部署，以及對遠端醫療和遠端患者監護的強勁需求，正促使醫療系統和設備製造商優先考慮快速試點部署互聯解決方案。北美買家高度關注網路安全和合規途徑，而支付方也越來越重視能夠大幅減少急診治療需求的醫療設備。該地區的採購流程往往傾向於能夠展現明確臨床和營運投資回報率的整合解決方案，醫療設備原始設備製造商 (OEM) 與主要網路供應商之間的夥伴關係也十分普遍，旨在降低部署風險。

對生態系統中供應商、整合商和軟體合作夥伴的競爭關係、夥伴關係模式和策略挑戰進行深入分析。

5G賦能的醫療設備領域的競爭動態由眾多參與者共同塑造，包括醫療設備製造商 (OEM)、網路營運商、雲端和分析供應商、系統整合商以及專業軟體供應商。醫療設備OEM正在拓展產品系列，將嵌入式連接和邊緣運算功能融入其中，並日益加強與通訊業者和整合商的合作，以在臨床環境中檢驗端到端解決方案。網路營運商和專用網路專家則將託管連接和保障服務定位為其臨床解決方案體系的重要組成部分，提供針對醫療應用場景量身定做的服務等級協定 (SLA) 和互通性保證。

為製造商、醫療保健系統和技術合作夥伴提供優先考慮的、可操作的建議，以加速安全且可擴展的部署。

計劃使用5G醫療設備的領導者應優先考慮制定一套切實可行的策略，使技術能力與臨床和商業性目標保持一致。首先，為了降低網路風險並滿足監管要求，應從產品初始設計到上市後監測都遵循「安全設計」和零信任架構的原則。儘早投資於硬體模組化和軟體定義無線電（SDR）技術，將使產品能夠在非獨立組網（NSA）、獨立組網（SA）和專用網路配置下運行，從而降低重新設計成本並加快部署準備。

對結合一手訪談、技術檢驗、供應鏈映射和情境分析的多方面研究途徑進行透明的解釋。

本研究採用多方面方法，旨在從技術、臨床和商業性觀點交叉檢驗5G醫療設備。主要定性資料透過對臨床負責人、設備工程師、網路專家和採購主管的結構化訪談獲得，以直接了解部署經驗和挑戰。專家小組檢驗了有關無線電波傳播、邊緣運算部署和互通性限制的技術假設。次要研究涵蓋標準文件、監管指南、技術白皮書和公開案例研究，並基於既定實踐和近期部署情況進行分析。

簡潔的結論強調了將 5G 技術能力轉化為臨床價值和永續商業性優勢的關鍵優先事項。

將可靠的 5G 連線部署到醫療設備中，為重塑臨床工作流程、擴展遠距醫療模式以及提高診斷和治療性介入的準確性帶來了變革性的機會。要實現這一潛力，需要醫療設備製造商、網路供應商、醫療系統、監管機構和保險公司通力合作，協調產品設計、連接保障、臨床檢驗和商業性獎勵。無論產品類型和應用領域如何，通用要素包括：確定性的效能、安全且可審計的資料處理，以及可證明的臨床價值—將連接性視為設備固有的屬性而非附加功能。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：5G相容醫療設備市場：依產品類型分類

  • 診斷設備
    • 診斷影像
      • CT掃描儀
      • 核磁共振掃描儀
      • 超音波診斷設備
    • 臨床檢測
      • 血液分析儀
      • 尿液檢查裝置
    • 即時診斷
  • 監控設備
    • 心電圖監測
      • 居家心電圖監測
      • 醫院用心電圖監測
    • 血糖監測
      • 持續血糖監測
      • 間歇性血糖監測
    • 呼吸監測
      • 睡眠呼吸中止監測
      • 肺功能監測
    • 生命徵象監測
      • 血壓監測
      • 心率監測
      • 體溫監測
  • 治療設備
    • 點滴幫浦
      • 胰島素注射
      • 點滴鎮痛
    • 胰島素幫浦
      • 補片泵浦
      • 管式幫浦
    • 神經刺激設備
      • 深部腦部刺激器
      • 脊髓刺激設備
    • 呼吸治療設備
      • CPAP設備
      • 人工呼吸器

第9章：按連線類型分類的5G相容醫療設備市場

  • 非獨立組網 5G
    • 毫米波
    • 低於 6GHz
  • 私有5G
    • 校園網路
    • 工業網路
  • 獨立組網 5G
    • 毫米波
    • 低於 6GHz

第10章：以網路架構分類的5G相容醫療設備市場

  • 混合網路
    • 邊緣整合
    • 本地核心
  • 私人網路
    • 校園網路
    • 企業網路
  • 公共網路
    • MVNO
    • 通訊業者網路

第11章：5G相容醫療設備市場：按組件分類

  • 硬體
    • 天線
    • 模組
      • 連接模組
      • 電源模組
    • 感應器
  • 服務
    • 諮詢服務
    • 綜合服務
    • 維護服務
  • 軟體
    • 分析軟體
    • 行動應用
    • 平台

第12章：5G相容醫療設備市場：依應用領域分類

  • 資產追蹤
    • 裝置追蹤
      • 設備位置
      • 穿戴式資產追蹤
    • 供應鏈監控
      • 低溫運輸監測
      • 庫存視覺化
  • 緊急應變
    • 救護車服務
      • 移動診斷
      • 緊急情況下的遠端醫療
    • 災害管理
      • 野戰醫院的建設
      • 遠端協作
  • 遠端患者監護
    • 慢性病管理
      • 心臟護理
      • 糖尿病管理
    • 老年護理
      • 活動監測
      • 跌倒偵測
    • 術後護理
      • 疼痛管理
      • 傷口監測
  • 智慧醫院
    • 資產管理
      • 裝置追蹤
      • 庫存管理
    • 即時定位服務
      • 資產追蹤
      • 患者追蹤
    • 員工管理
      • 員工追蹤
      • 工作流程最佳化
  • 遠端醫療
    • 緊急遠距會診
      • 救護車遠端保健
      • 災難遠距遠距照護
    • 視訊諮詢
      • 人工智慧輔助診斷
      • 即時高清影像
    • 虛擬重症監護室
      • 警報管理
      • 遠端患者監護

第13章：5G相容醫療設備市場：依最終用戶分類

  • 門診手術中心
    • 醫院相關
    • 獨立的
  • 診所
    • 門診部
    • 專科診所
  • 居家醫療
    • 病人家
    • 老年護理機構
  • 醫院
    • 私立醫院
    • 公立醫院
  • 遠端醫療提供者
    • 平台提供者
    • 服務聚合器

第14章：5G相容醫療設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：5G相容醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：5G賦能的醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國5G相容醫療設備市場

第18章：中國的5G相容醫療設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bharti Airtel Limited
  • Boston Scientific Corporation
  • China Mobile Limited
  • Deutsche Telekom AG
  • Fibocom Wireless Inc.
  • GE Healthcare Technologies Inc.
  • General Electric Company
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Quectel Wireless Solutions Co., Ltd.
  • Samsung Electronics Co., Ltd
  • Siemens Healthineers AG
  • Sierra Wireless, Inc.
  • Swisscom AG
  • Telefonica, SA
  • Vodafone Group Public Limited Company
  • ZTE Corporation
Product Code: MRR-AD517FAA8AD0

The 5G-enabled Medical Devices Market was valued at USD 1.22 billion in 2025 and is projected to grow to USD 1.51 billion in 2026, with a CAGR of 23.62%, reaching USD 5.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.51 billion
Forecast Year [2032] USD 5.38 billion
CAGR (%) 23.62%

An authoritative introduction outlining how fifth-generation connectivity is redefining clinical devices and delivery models across healthcare ecosystems

The deployment of fifth-generation wireless connectivity is reshaping the design, delivery, and management of medical devices across clinical and non-clinical settings. This report examines how deterministic connectivity, ultra-low latency, and high device density enable new classes of diagnostic, monitoring, and therapeutic devices while imposing fresh requirements on cybersecurity, regulatory compliance, and clinical validation. Stakeholders from device manufacturers to health system operators and network providers confront a rapidly evolving technical and commercial landscape where interoperability, data integrity, and patient safety sit at the intersection of innovation and regulation.

As care delivery models continue to decentralize, the interplay between on-premise infrastructure and cloud-based analytics is becoming central to device value propositions. Remote patient management, telehealth modalities, and smart hospital initiatives now depend on predictable connectivity and resilient network architectures. Consequently, product road maps are shifting to embed network adaptability, edge compute capabilities, and secure telemetry from initial design phases.

The introduction frames current dynamics by describing the principal technological enablers and the operational pressures that drive adoption. It also identifies the core stakeholders whose choices will determine how rapidly the theoretical benefits of 5G become realized in everyday clinical workflows. Finally, the introduction outlines the report's scope and analytical approach, setting expectations for how subsequent sections translate complex technical trends into operational priorities for device manufacturers, health systems, and technology partners.

A concise analysis of the major technological, regulatory, and operational shifts that are accelerating adoption and raising the bar for clinical-grade connectivity

The last several years have seen a suite of transformative shifts that are accelerating the adoption of connected medical devices and reframing clinical workflows. First, the maturation of edge computing and distributed analytics has reduced the friction between data capture and clinical action, enabling real-time decision support for high-acuity use cases. At the same time, the expansion of private and hybrid network deployments has created controlled connectivity environments where latency, throughput, and security parameters can be managed to meet clinical grade requirements.

Second, advances in radio access technologies and spectrum allocation-particularly the dual play of mmWave and Sub6GHz bands-are unlocking differentiated performance capabilities that map directly to device classes such as high-resolution imaging and continuous physiological monitoring. This technical diversity is prompting OEMs to pursue modular hardware and software architectures that can operate across NonStandalone, Standalone, and private 5G configurations.

Third, the convergence of AI-driven analytics with richer telemetry has increased the clinical value of continuous monitoring and point-of-care diagnostics, while simultaneously raising expectations for explainability, validation, and governance. Regulatory frameworks and reimbursement pathways are adapting, but unevenly, which means innovators must navigate heterogeneous approval landscapes and payer incentives. Finally, cybersecurity threats have intensified as devices proliferate and edge compute surfaces expand. As a result, secure-by-design practices, zero-trust architectures, and supply chain transparency are no longer optional but essential components of go-to-market strategies. Collectively, these shifts are creating both new opportunities for clinical impact and heightened requirements for cross-industry collaboration.

A pragmatic assessment of how US tariff measures in 2025 have reshaped supply chain strategies, procurement dynamics, and device deployment timelines

The United States tariff environment implemented in 2025 has introduced a series of cumulative effects that ripple through supply chains, procurement strategies, and product cost structures for medical device manufacturers reliant on global component sourcing. Manufacturers that depend on foreign-produced radios, semiconductor modules, or specialized sensors are encountering elevated landed costs and longer lead times, which in turn forces reprioritization of procurement pipelines and inventory management. These pressures create incentives for diversification of suppliers, increased onshoring of critical components, and strategic partnership agreements that can buffer exposure to future policy changes.

Procurement teams within health systems and device OEMs are reassessing vendor agreements to lock in pricing or shift to alternative suppliers with more favorable tariff exposure. Clinical device procurement cycles may lengthen as contracting stakeholders require additional due diligence around total cost of ownership, including tariff-related variability. From a regulatory and certification perspective, shifting components to new suppliers or manufacturing sites necessitates renewed testing and documentation, potentially extending time-to-deployment for devices undergoing wireless integration or clinical trials.

Investors and corporate strategy teams are responding by accelerating supply chain mapping and scenario planning, focusing on supplier concentration risks and redesign opportunities that reduce dependency on tariff-exposed inputs. At the same time, network operators and integrators who provide private and hybrid 5G services are adjusting commercial models to accommodate procurement uncertainty among their device customers. The net effect is an environment where strategic resilience, flexible architecture design, and supplier relationships become decisive competitive differentiators in the rollout of 5G-enabled medical technologies.

A comprehensive and integrated segmentation analysis showing how product types, applications, end users, connectivity, architecture, and components influence strategy and design

Segmentation reveals how adoption patterns and product design priorities diverge across device classes, application domains, end users, connectivity types, network architectures, and component stacks. In product type segmentation, diagnostic devices include imaging diagnostics, laboratory diagnostics, and point-of-care diagnostics where imaging diagnostics further bifurcate into CT scanners, MRI scanners, and ultrasound devices while laboratory diagnostics separate into blood analyzers and urinalysis analyzers; these high-bandwidth, high-accuracy instruments prioritize throughput, deterministic connectivity, and secure data pipelines. Monitoring devices encompass cardiac monitoring, glucose monitoring, respiratory monitoring, and vital signs monitoring, with cardiac monitoring split into home and hospital categories, glucose monitoring differentiated between continuous and intermittent approaches, respiratory monitoring addressing sleep apnea and spirometry, and vital signs monitoring covering blood pressure, heart rate, and temperature; these monitoring segments prioritize low power consumption, continuity of telemetry, and robust edge analytics. Therapeutic devices include infusion pumps, insulin pumps, neurostimulators, and respiratory therapy devices, with infusion pumps subdivided into insulin infusion and pain management infusion, insulin pumps into patch and tubed variants, neurostimulators into deep brain and spinal cord stimulators, and respiratory therapy devices into CPAP machines and ventilators; therapeutic segments demand ultra-reliable connectivity, fail-safe behaviors, and rigorous device interoperability.

Application segmentation groups solutions across asset tracking, emergency response, remote patient monitoring, smart hospital, and telemedicine. Asset tracking separates into device tracking and supply chain monitoring where device tracking parses into equipment positioning and wearable asset tracking while supply chain monitoring splits into cold chain oversight and inventory visibility. Emergency response includes ambulance services and disaster management, with ambulance services further distinguishing mobile diagnostics and prehospital telehealth and disaster management covering field hospital enablement and remote coordination. Remote patient monitoring subdivides into chronic disease management, elderly care, and postoperative care; chronic disease management further divides into cardiac care and diabetes management, elderly care emphasizes activity monitoring and fall detection, and postoperative care focuses on pain and wound monitoring. Smart hospital use cases include asset management, real-time location services, and staff management, with asset management covering equipment tracking and inventory control, real-time location services differentiating between asset and patient tracking, and staff management addressing personnel tracking and workflow optimization. Telemedicine includes emergency teleconsultation, video consultation, and virtual ICU where emergency teleconsultation separates into ambulance telehealth and disaster telecare, video consultation benefits from AI-assisted diagnostics and real-time HD video, and virtual ICU focuses on alarm management and remote surveillance.

End-user segmentation captures ambulatory surgical centers, clinics, home healthcare, hospitals, and telehealth providers. Ambulatory surgical centers are classified as hospital-affiliated or independent while clinics differentiate outpatient and specialty clinics. Home healthcare distinguishes between patient homes and senior care facilities. Hospitals classify as private or public, and telehealth providers separate into platform providers and service aggregators. Connectivity type segmentation contrasts NonStandalone 5G, Private 5G, and Standalone 5G; NonStandalone and Standalone each extend across mmWave and Sub6GHz bands, while Private 5G distinguishes campus networks and industrial networks. Network architecture segmentation contrasts hybrid, private, and public networks where hybrid architectures emphasize edge integration and on-premise core options, private networks break down into campus and enterprise footprints, and public networks cover MVNO and operator-managed models. Component segmentation clarifies hardware, services, and software requirements; hardware covers antennas, modules, and sensors with modules split into connectivity and power variants, services encompass consulting, integration, and maintenance, and software ranges from analytics suites to mobility applications and platform orchestration. Together, these layered segmentation perspectives illuminate where design trade-offs, commercialization tactics, and clinical validation efforts must be concentrated for each product and use-case class.

A strategic regional overview explaining how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption drivers and deployment priorities

Regional dynamics materially influence technology adoption curves, regulatory priorities, and commercial partnerships across the 5G-enabled medical device landscape. In the Americas, health systems and device manufacturers emphasize rapid trials of connectivity-enabled solutions, driven by a combination of private network pilots in academic medical centers and strong demand for telemedicine and remote patient monitoring. North American purchasers exhibit heightened sensitivity to cybersecurity and compliance pathways, and payers increasingly reward devices that deliver measurable reductions in acute care utilization. Procurement cycles in this region tend to favor integrated solutions that demonstrate clear clinical and operational ROI, and partnerships between device OEMs and large network providers are common to de-risk deployments.

In Europe, Middle East & Africa, regulatory harmonization and cross-border interoperability are central themes. European Union regulatory frameworks and national health systems drive technical and clinical standards, creating a premium for devices that can demonstrate multi-jurisdictional compliance. In the Middle East, rapid investments in smart hospital infrastructures and private network deployments foster early-adopter environments, while parts of Africa present unique opportunities for low-bandwidth, resilient connectivity models that prioritize cost-effective remote care and supply chain visibility. Across the region, public-private partnerships and consortium approaches frequently accelerate infrastructure deployments and clinical pilots.

Asia-Pacific exhibits a mix of advanced manufacturing capability and aggressive digital health adoption. Several markets in this region lead in private 5G deployments and large-scale smart hospital initiatives, and there is substantial momentum around integrating AI diagnostics with high-throughput imaging equipment. At the same time, variation in reimbursement models and fragmented clinical procurement channels requires vendors to tailor go-to-market strategies by country. Supply chain resilience is a strategic priority here as manufacturers balance proximity to component ecosystems with the need to mitigate tariff and geopolitical disruptions. Collectively, regional profiles underscore that device developers must align product strategies with localized regulatory, reimbursement, and infrastructure realities to accelerate adoption and scale.

An incisive review of competitive roles, partnership models, and strategic imperatives shaping providers, integrators, and software partners in the ecosystem

Competitive dynamics in the 5G-enabled medical device space are shaped by a diverse set of players including device OEMs, network operators, cloud and analytics providers, systems integrators, and specialized software vendors. Device OEMs are extending their product portfolios to incorporate embedded connectivity and edge compute capabilities, and they increasingly partner with telecom providers and integrators to validate end-to-end solutions in clinical environments. Network operators and private network specialists are positioning managed connectivity and assurance services as an integral part of clinical solution stacks, offering service-level agreements and interoperability guarantees tailored to healthcare use cases.

Cloud and analytics vendors contribute scalable compute and AI capabilities that accelerate the translation of raw telemetry into clinically actionable insights, while systems integrators play a crucial role in orchestrating device interoperability, clinical workflow integration, and onsite deployment. Software developers focusing on device management, mobility applications, and analytics platforms bring domain expertise in data normalization, device lifecycle management, and regulatory documentation. Startups and niche vendors often advance specialized capabilities-such as low-power telemetry modules or explainable AI for diagnostics-that incumbents can acquire or integrate through strategic partnerships.

Strategic imperatives for market players include demonstrating clinical utility through rigorous validation, ensuring secure and auditable data flows, and building commercial models that align with payer incentives. Partnerships that combine clinical credibility, network assurance, and cloud-native analytics tend to secure early deployments, while vertically integrated approaches may offer speed-to-market advantages in environments where procurement preferences favor single-vendor accountability. For many organizations, the path to scale lies in flexible alliance models that balance proprietary innovation with interoperable standards-based architectures.

A pragmatic set of prioritized, implementable recommendations for manufacturers, health systems, and technology partners to accelerate secure and scalable deployments

Leaders planning to capitalize on 5G-enabled medical devices should prioritize a set of concrete, actionable strategies that align technical capability with clinical and commercial objectives. First, incorporate secure-by-design principles and zero-trust architectures from initial product design through to post-market surveillance to mitigate cyber risk and satisfy regulatory expectations. Early investment in hardware modularity and software-defined radio approaches will allow products to operate across NonStandalone, Standalone, and private network configurations, reducing redesign costs and accelerating deployment readiness.

Second, establish diversified supplier relationships and regional manufacturing options to manage exposure to tariff and geopolitical shocks. Scenario-based supply chain modeling and multi-sourcing strategies will reduce single-point dependencies while preserving time-to-market. Third, develop rigorous clinical validation pathways that integrate connectivity performance as part of clinical endpoints; demonstrate not only device accuracy but also the reliability of end-to-end telemetry and the clinical impact of near-real-time decision support. Fourth, form pragmatic commercial partnerships with network providers, systems integrators, and analytics vendors to offer bundled solutions that match purchaser preferences for integrated accountability.

Fifth, engage proactively with regulators and payers to shape reimbursement and compliance frameworks that recognize the value of continuous monitoring, telemedicine, and edge analytics. Collaborative pilot programs with health systems can create compelling evidence for adoption and reimbursement. Finally, invest in workforce capabilities-both within product teams and customer support functions-so that organizations can manage complex hybrid deployments, provide rapid field support, and translate technical performance into clinician-facing value propositions.

A transparent explanation of the multi-method research approach combining primary interviews, technical validation, supply chain mapping, and scenario analysis

This research draws on a multi-method approach designed to triangulate technical, clinical, and commercial perspectives on 5G-enabled medical devices. Primary qualitative inputs included structured interviews with clinical leaders, device engineers, networking specialists, and procurement executives to capture firsthand implementation experiences and pain points. Expert panels validated technical assumptions related to radio propagation, edge compute placement, and interoperability constraints. Secondary research encompassed standards documentation, regulatory guidance, technical whitepapers, and publicly available case studies to ground the analysis in established practices and recent deployments.

Technical validation involved performance testing scenarios that map device bandwidth and latency requirements to NonStandalone, Standalone, and private 5G configurations, and architecture modeling examined trade-offs between on-premise cores, hybrid edge integration, and public network dependence. Supply chain mapping identified component concentration risks and potential mitigation strategies in the context of tariff-induced disruption. The synthesis applied scenario analysis to explore alternative adoption paths under differing regulatory, economic, and infrastructure conditions.

Limitations of the methodology include variability in regulatory timelines across jurisdictions and the pace of commercial deployments, which can affect the generalizability of individual case studies. To address these constraints, findings were cross-verified across multiple expert cohorts and technical representatives. The methodology emphasizes transparency in assumptions and provides clear traceability from empirical inputs to analytical conclusions, offering readers a robust foundation for strategic decision-making while acknowledging evolving dynamics in technology and policy.

A concise conclusion emphasizing the essential priorities for translating 5G technical capability into clinical value and sustainable commercial advantage

The introduction of reliable 5G connectivity into medical devices presents a transformative opportunity to reconfigure clinical workflows, expand remote care models, and enhance the fidelity of diagnostic and therapeutic interventions. Realizing this potential requires a coordinated response from device manufacturers, network providers, health systems, regulators, and payers that aligns product design, connectivity assurance, clinical validation, and commercial incentives. Across product types and application domains, the common threads are deterministic performance, secure and auditable data handling, and demonstrable clinical value that integrates connectivity as an intrinsic device attribute rather than an add-on.

Strategic resilience against tariff and supply chain disruptions is now a competitive necessity, prompting organizations to rethink sourcing, manufacturing footprint, and partnership strategies. Regionally differentiated adoption dynamics underscore the need for localization in regulatory strategy and go-to-market execution. Companies that combine modular product architectures, robust clinical evidence, and flexible commercial models will be best positioned to scale deployments and secure long-term partnerships with health systems.

In sum, the pathway to impact for 5G-enabled medical devices is clear: embed connectivity and security into design, validate clinical and operational performance rigorously, and pursue adaptive supply chain and partnership strategies that align with evolving regulatory and procurement landscapes. Stakeholders that act decisively on these priorities can accelerate the translation of technical capability into measurable improvements in care delivery and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 5G-enabled Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Diagnostics
      • 8.1.1.1. CT Scanners
      • 8.1.1.2. MRI Scanners
      • 8.1.1.3. Ultrasound Devices
    • 8.1.2. Laboratory Diagnostics
      • 8.1.2.1. Blood Analyzer
      • 8.1.2.2. Urinalysis Analyzer
    • 8.1.3. Point Of Care Diagnostics
  • 8.2. Monitoring Devices
    • 8.2.1. Cardiac Monitoring
      • 8.2.1.1. Home Cardiac Monitoring
      • 8.2.1.2. Hospital Cardiac Monitoring
    • 8.2.2. Glucose Monitoring
      • 8.2.2.1. Continuous Glucose Monitoring
      • 8.2.2.2. Intermittent Glucose Monitoring
    • 8.2.3. Respiratory Monitoring
      • 8.2.3.1. Sleep Apnea Monitoring
      • 8.2.3.2. Spirometry Monitoring
    • 8.2.4. Vital Signs Monitoring
      • 8.2.4.1. Blood Pressure Monitoring
      • 8.2.4.2. Heart Rate Monitoring
      • 8.2.4.3. Temperature Monitoring
  • 8.3. Therapeutic Devices
    • 8.3.1. Infusion Pumps
      • 8.3.1.1. Insulin Infusion
      • 8.3.1.2. Pain Management Infusion
    • 8.3.2. Insulin Pumps
      • 8.3.2.1. Patch Pumps
      • 8.3.2.2. Tubed Pumps
    • 8.3.3. Neurostimulators
      • 8.3.3.1. Deep Brain Stimulators
      • 8.3.3.2. Spinal Cord Stimulators
    • 8.3.4. Respiratory Therapy Devices
      • 8.3.4.1. CPAP Machines
      • 8.3.4.2. Ventilators

9. 5G-enabled Medical Devices Market, by Connectivity Type

  • 9.1. NonStandalone 5G
    • 9.1.1. MmWave
    • 9.1.2. Sub6GHz
  • 9.2. Private 5G
    • 9.2.1. Campus Network
    • 9.2.2. Industrial Network
  • 9.3. Standalone 5G
    • 9.3.1. MmWave
    • 9.3.2. Sub6GHz

10. 5G-enabled Medical Devices Market, by Network Architecture

  • 10.1. Hybrid Network
    • 10.1.1. Edge Integrated
    • 10.1.2. On-Premise Core
  • 10.2. Private Network
    • 10.2.1. Campus Network
    • 10.2.2. Enterprise Network
  • 10.3. Public Network
    • 10.3.1. MVNO
    • 10.3.2. Operator Network

11. 5G-enabled Medical Devices Market, by Component

  • 11.1. Hardware
    • 11.1.1. Antennas
    • 11.1.2. Modules
      • 11.1.2.1. Connectivity Modules
      • 11.1.2.2. Power Modules
    • 11.1.3. Sensors
  • 11.2. Services
    • 11.2.1. Consulting Services
    • 11.2.2. Integration Services
    • 11.2.3. Maintenance Services
  • 11.3. Software
    • 11.3.1. Analytics Software
    • 11.3.2. Mobility Applications
    • 11.3.3. Platforms

12. 5G-enabled Medical Devices Market, by Application

  • 12.1. Asset Tracking
    • 12.1.1. Device Tracking
      • 12.1.1.1. Equipment Positioning
      • 12.1.1.2. Wearable Asset Tracking
    • 12.1.2. Supply Chain Monitoring
      • 12.1.2.1. Cold Chain Monitoring
      • 12.1.2.2. Inventory Visibility
  • 12.2. Emergency Response
    • 12.2.1. Ambulance Services
      • 12.2.1.1. Mobile Diagnostics
      • 12.2.1.2. Prehospital Telehealth
    • 12.2.2. Disaster Management
      • 12.2.2.1. Field Hospital Enablement
      • 12.2.2.2. Remote Coordination
  • 12.3. Remote Patient Monitoring
    • 12.3.1. Chronic Disease Management
      • 12.3.1.1. Cardiac Care
      • 12.3.1.2. Diabetes Management
    • 12.3.2. Elderly Care
      • 12.3.2.1. Activity Monitoring
      • 12.3.2.2. Fall Detection
    • 12.3.3. Postoperative Care
      • 12.3.3.1. Pain Management
      • 12.3.3.2. Wound Monitoring
  • 12.4. Smart Hospital
    • 12.4.1. Asset Management
      • 12.4.1.1. Equipment Tracking
      • 12.4.1.2. Inventory Management
    • 12.4.2. Real-Time Location Services
      • 12.4.2.1. Asset Tracking
      • 12.4.2.2. Patient Tracking
    • 12.4.3. Staff Management
      • 12.4.3.1. Personnel Tracking
      • 12.4.3.2. Workflow Optimization
  • 12.5. Telemedicine
    • 12.5.1. Emergency Teleconsultation
      • 12.5.1.1. Ambulance Telehealth
      • 12.5.1.2. Disaster Telecare
    • 12.5.2. Video Consultation
      • 12.5.2.1. AI-Assisted Diagnostics
      • 12.5.2.2. Real-Time HD Video
    • 12.5.3. Virtual ICU
      • 12.5.3.1. Alarm Management
      • 12.5.3.2. Remote Patient Surveillance

13. 5G-enabled Medical Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital-Affiliated
    • 13.1.2. Independent
  • 13.2. Clinics
    • 13.2.1. Outpatient Clinics
    • 13.2.2. Specialty Clinics
  • 13.3. Home Healthcare
    • 13.3.1. Patient Homes
    • 13.3.2. Senior Care Facilities
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals
  • 13.5. Telehealth Providers
    • 13.5.1. Platform Providers
    • 13.5.2. Service Aggregators

14. 5G-enabled Medical Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. 5G-enabled Medical Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. 5G-enabled Medical Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States 5G-enabled Medical Devices Market

18. China 5G-enabled Medical Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Baxter International Inc.
  • 19.7. Becton, Dickinson and Company
  • 19.8. Bharti Airtel Limited
  • 19.9. Boston Scientific Corporation
  • 19.10. China Mobile Limited
  • 19.11. Deutsche Telekom AG
  • 19.12. Fibocom Wireless Inc.
  • 19.13. GE Healthcare Technologies Inc.
  • 19.14. General Electric Company
  • 19.15. Intel Corporation
  • 19.16. Johnson & Johnson
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Medtronic plc
  • 19.19. Quectel Wireless Solutions Co., Ltd.
  • 19.20. Samsung Electronics Co., Ltd
  • 19.21. Siemens Healthineers AG
  • 19.22. Sierra Wireless, Inc.
  • 19.23. Swisscom AG
  • 19.24. Telefonica, S.A.
  • 19.25. Vodafone Group Public Limited Company
  • 19.26. ZTE Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC CARE, BY REG